Table 5.

XAGE-1b antibody responses in lung cancer patients

PatientsNo. positive/sera tested
Adenocarcinoma5*/56
Squamous cell carcinoma0/17
Carcinoid0/1
Total5/74
Healthy donors0/40
  • * The difference in seropositive frequency between patients with adenocarcinoma and other histologic types was not statistically significant (P = 0.1542).